A Randomized, Multicenter, Sham Controlled, Double-Masked, Phase 2/3 Study Assessing Efficacy and Safety of Betamethasone Microsphere in Patients With Diabetic Macular Edema.
Phase of Trial: Phase II/III
Latest Information Update: 08 Aug 2014
At a glance
- Drugs Betamethasone (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- Acronyms TSUBASA
- Sponsors Santen Pharmaceutical
- 18 Jul 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 11 Aug 2011 New trial record